{"ticker": {"uuid": "234f695e-568e-4f26-bf69-fc026437177a", "symbol": "ELUT", "name": "Elutia Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia Inc. (ELUT) Bounces From Support, Tests Key Resistance at $1.01 - RVOL Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOZHVYRGxIbXIzN3VjNkczS3VBR0FaN2I3ZWdNNFNKcXhPQ1VvZE9BWm40WWJlMUxsNVQ4dG90RVU5SGx2ZmR1QUFJZE9PbllGcXVlRlZQakZlNlNuV29EdkVtX1lrZTZMSDlOMVh1b1lKVTNpOXdjdE82TWVQTTVhT2NWdm5lUGJZSS1sd0RfMS0yaDd3MF9vQTJIcmFrZFlUR0ExeTVNaHpfZGEz?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-07T23:47:36+00:00", "published_display": "07 Jul 2026 23:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $5", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOakl3OFRuQXZTMEFZR2lqR2FNWGxFNl8tODdkMENCaE5EM0lESWVmcjQxTTM3SE84Z2dWdHNlV05sT2txMENvWTI2Uk5tMkhCcDZjNFJuWlZ6YTBXQ05fUEszaHF5Q1lLTnQ0WVFSQ2prdmk2TUlkcHQwYXJEdy04VUdQOHRjSGlDb2xjbDJQYkJ1cmFQTEhIRWZ1Vm9TTFR5WkZlMFBaQWVCT3p1NkE?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-07T18:20:20+00:00", "published_display": "07 Jul 2026 18:20", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc Class A Actuals & Estimates (NASDAQ:ELUT)", "summary": "This article provides an overview of Elutia, Inc. (NASDAQ: ELUT) stock performance, financial data, and analyst forecasts. It covers the current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings reports, indicating that analysts have", "url": "https://www.tradingview.com/symbols/NASDAQ-ELUT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:10:08", "published_display": "26 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Elutia Inc For: 22 June By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Elutia Inc. on June 22. It mentions Elutia Inc. with the stock symbol ELUT, which experienced a 4.75% decrease, and includes general market data and news headlines. The content is primarily a placeholder for a fin", "url": "https://ca.investing.com/news/stock-market-news/form-4-elutia-inc-for-22-june-93CH-4701957", "source_name": "Investing.com Canada", "published_at": "2026-06-23T20:11:49", "published_display": "23 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) CEO reports RSU vesting and tax withholding, boosting share holdings", "summary": "Elutia Inc.'s President and CEO, C. Randal Mills, reported the vesting of 22,473 restricted stock units (RSUs) into Class A Common Stock. As part of this transaction, 8,064 shares were withheld by the company to cover tax obligations. Following these transactions, Mills directly ", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-786b9689d1d1.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:40:48", "published_display": "22 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Shareholders Approve Amended Incentive Plan and Governance", "summary": "Elutia shareholders have approved an amended 2020 equity incentive plan, increasing available shares by 3,000,000 Class A common shares and extending the plan's duration. They also elected directors, ratified PricewaterhouseCoopers LLP as auditor, and approved executive compensat", "url": "https://www.tipranks.com/news/company-announcements/elutia-shareholders-approve-amended-incentive-plan-and-governance", "source_name": "TipRanks", "published_at": "2026-06-17T23:39:55", "published_display": "17 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) investors approve equity plan amendment and annual say-on-pay", "summary": "Elutia Inc. (ELUT) stockholders approved an amendment to its 2020 Incentive Award Plan, authorizing an additional 3,000,000 shares for awards and extending the plan's duration. All other proposals also passed, including the election of two Class III directors, the ratification of", "url": "https://www.stocktitan.net/sec-filings/ELUT/8-k-elutia-inc-reports-material-event-46ba78ed20e0.html", "source_name": "Stock Titan", "published_at": "2026-06-17T17:40:54", "published_display": "17 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc. (NASDAQ: ELUT) Files 8-K with Updated Company Information and Key SEC Details \u2013 June 2026", "summary": "Elutia Inc. (NASDAQ: ELUT) filed an 8-K detailing key outcomes from its annual meeting on June 11, 2026. Shareholders approved the First Amendment to the 2020 Incentive Award Plan, elected two Class III Directors, and ratified PricewaterhouseCoopers LLP as auditors for FY2026. Ad", "url": "https://www.minichart.com.sg/2026/06/17/elutia-inc-nasdaq-elut-files-8-k-with-updated-company-information-and-key-sec-details-june-2026/", "source_name": "Minichart", "published_at": "2026-06-17T09:47:00", "published_display": "17 Jun 2026 09:47", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Q1 2026 Earnings: EPS Misses Estimates Amid Operational Challenges - Share Dilution Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPcEZ6WG5zZkNsUjUxbVp5SU5iU05wY0hGNXY3RjU4ZVpkXzY0WVVlWGlROEJGdXEzdUduWW1WYmE5dkZOUzVNVlAxVUhmZHdVd1AwYm1BRDEzaFdqczFLNkFHdGxhRF9TYklaUXd2SDVybjFTRW1wTEllWUFZUzFiRzFPSlFXcHZndVFjYTNGZG15cmlDN1lORDQ4My0zM2xQUVBYcFRwUjNPLWV6QW1QVjVHNE85bHg5RGkw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia (NASDAQ: ELUT) director Brigid Makes receives 106,393-share stock option grant", "summary": "Elutia (NASDAQ: ELUT) director Brigid Makes was granted stock options for 106,393 shares of Class A common stock as part of the company\u2019s Non-Employee Director Compensation Program. The options have an exercise price of $0.9600 per share and expire on June 11, 2036. This grant is", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-5d91513660b4.html", "source_name": "Stock Titan", "published_at": "2026-06-16T05:10:31", "published_display": "16 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) director awarded 106K stock options as compensation", "summary": "Elutia (NASDAQ: ELUT) director David Colpman received a grant of 106,393 stock options as compensation, with an exercise price of $0.96 per share. These options are not an open-market trade and will vest upon the earlier of the day before Elutia's first annual meeting following t", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-c3526816a7b5.html", "source_name": "Stock Titan", "published_at": "2026-06-16T04:40:26", "published_display": "16 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) grants director Kevin Rakin 159,590 stock options", "summary": "Elutia Inc. director and 10% owner Kevin Rakin has been granted 159,590 stock options for Class A Common Stock at an exercise price of $0.96 per share. These options, part of the company's Non-Employee Director Compensation Program, will vest based on his continued board service ", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-d274f8a43f00.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:40:26", "published_display": "15 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) director receives 106,393 stock options at $0.96 strike", "summary": "Elutia (NASDAQ: ELUT) director Guido J. Neels was granted 106,393 stock options with an exercise price of $0.96 per share. This grant was made automatically under the company\u2019s Non-Employee Director Compensation Program. The options vest upon the earlier of the first annual meeti", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-c03b46b5b2c5.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:40:26", "published_display": "15 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ELUTIA (ELUT) CSO reports RSU vesting and tax withholding share disposition", "summary": "ELUTIA's Chief Scientific Officer, Michelle LeRoux Williams, reported the vesting of 12,500 restricted stock units (RSUs) into Class A Common Stock on June 10, 2026. Concurrently, 4,269 shares were withheld at $1.04 each to cover tax obligations. Following these transactions, Wil", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-212e7de2564d.html", "source_name": "Stock Titan", "published_at": "2026-06-13T03:38:56", "published_display": "13 Jun 2026 03:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) CFO reports RSU vesting and tax withholding event", "summary": "Elutia Inc.'s CFO, Matthew Ferguson, reported the vesting of 12,500 restricted stock units (RSUs) into Class A common stock. To cover tax withholding obligations, 4,485 shares were withheld by the company at an implied price of $1.04 per share. Following these transactions, Fergu", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-b44f85cfae02.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:56", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) CEO RSUs vest; shares withheld to cover taxes", "summary": "Elutia Inc.'s President and CEO, C. Randal Mills, had 27,083 restricted stock units (RSUs) vest on June 10, 2026, which converted into Class A common shares. To cover tax withholding requirements, 9,718 Class A shares were withheld by the issuer at $1.04 per share. Following thes", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-1c680e41e29b.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:56", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia to Present at Planet MicroCap Showcase 2026 on June 17th", "summary": "Elutia Inc. will present at the Planet MicroCap Showcase 2026 on June 17th, with CEO Dr. Randy Mills and CSO Dr. Michelle Williams hosting one-on-one meetings with investors. Management will discuss Elutia's drug-eluting biomatrix technology, which aims to address post-surgical i", "url": "https://sg.finance.yahoo.com/news/elutia-present-planet-microcap-showcase-200500866.html", "source_name": "Market source", "published_at": "2026-06-11T20:05:00", "published_display": "11 Jun 2026 20:05", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc. (ELUT) Slips Nearly 5% as Stock Tests Key Support Levels - Shakeout Pattern", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNSGhEZVROeE9CblRGMFExQjFJUTE0eUowZGZ6NGhya05HVEtILXA0eE8xRGxxM2VoZkZ3ZXliRVgwWVV2bXdXV2prbkQxSmZQeW9TVUVRQjMzQnFfSlJIMnhILV9GUVN2SnhJRmRwT3Y3SHlRQmxPQm1Janc3NHR5ZFNYSmF2dHRvX2lpMnBPRHZoT3hndURqbTE1bHkySEZOVG5saE1PajJlRGxv?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Despite Elutia's Pullback, Insiders Still Gained US$75k", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) director gifts shares and updates trust, HighCape stakes", "summary": "Kevin Rakin, a director and ten percent owner of Elutia (ELUT), along with affiliated HighCape entities, reported internal share movements rather than market trades. These transactions included a bona fide gift of 70,000 shares and a 50,000-share distribution from trusts to benef", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-a218a7430792.html", "source_name": "Stock Titan", "published_at": "2026-06-02T20:10:18", "published_display": "02 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)", "summary": "Elutia Inc. announced that it granted equity awards to one new employee on May 13, 2026, as an inducement award under its 2026 Inducement Award Plan. The award, consisting of 48,000 non-qualified stock options, was approved by the Compensation Committee and granted in accordance ", "url": "https://www.sahmcapital.com/news/content/elutia-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4-2026-05-18", "source_name": "Sahm", "published_at": "2026-05-19T08:09:39", "published_display": "19 May 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Reports First Quarter 2026 Results and Highlights", "summary": "Elutia Inc. reported its first quarter 2026 results, highlighting significant progress in its NXT-41x drug-eluting biomatrix technology aimed at the $1.5 billion U.S. plastic and reconstructive surgery market. The company advanced its FDA review process, brought a new automated m", "url": "https://www.globenewswire.com/news-release/2026/05/14/3295372/0/en/elutia-reports-first-quarter-2026-results-and-highlights-nxt-41x-progress-toward-1-5-billion-u-s-plastic-and-reconstructive-surgery-market.html", "source_name": "GlobeNewswire", "published_at": "2026-05-17T06:40:20", "published_display": "17 May 2026 06:40", "sentiment": "positive", "sentiment_pct": 78, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "About Us | Oil & Gas Journal - Elutia, Inc. - Class A Common Stock (Nasdaq:ELUT) Stock Quote", "summary": "This page provides a detailed stock quote for Elutia, Inc. (Nasdaq: ELUT), including current trading information, historical prices, performance data, and an archive of recent news and earnings reports. The stock closed at $1.030 on May 15, 2026, with a slight decrease of 0.96%, ", "url": "https://markets.financialcontent.com/pennwell.pennenergy/quote?Symbol=537%3A2578417618", "source_name": "FinancialContent", "published_at": "2026-05-16T04:10:08", "published_display": "16 May 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/5f18ce7a-19a5-3ce2-a378-2aebbed03faf/elutia-%28elut%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-15T12:58:03+00:00", "published_display": "15 May 2026 12:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/b34b80a4-9c37-35c8-a41b-35f8ded35f44/elutia-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-15T12:30:00+00:00", "published_display": "15 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia to Present at the 16th Annual LD Micro Invitational on May 18th", "summary": "Elutia Inc. (Nasdaq: ELUT) announced that its CEO, Dr. Randy Mills, and CFO, Matt Ferguson, will present at the 16th Annual LD Micro Invitational on May 18, 2026. They will discuss the company's drug-eluting biomatrix technology, which aims to address post-surgical infection in i", "url": "https://www.sahmcapital.com/news/content/elutia-to-present-at-the-16th-annual-ld-micro-invitational-on-may-18th-2026-05-14", "source_name": "Sahm", "published_at": "2026-05-15T08:39:02", "published_display": "15 May 2026 08:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Shifts", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/elutia-inc-elut-q1-2026-050112032.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:01:12+00:00", "published_display": "15 May 2026 05:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/elutia-reports-first-quarter-2026-200500939.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T20:05:00+00:00", "published_display": "14 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia to Present at the 16th Annual LD Micro Invitational May 18th", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/elutia-present-16th-annual-ld-200100167.html", "source_name": "TMX Newsfile", "published_at": "2026-05-14T20:01:00+00:00", "published_display": "14 May 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) Q1 loss deepens while NXT-41 pipeline and margins progress", "summary": "Elutia Inc. (NASDAQ: ELUT) reported a wider net loss of $7.5 million in Q1 2026, despite slightly higher revenue of $3.1 million, as the company continues to invest in its drug-eluting biomatrix platform. Gross margins improved significantly, with GAAP at 57.9% and adjusted at 66", "url": "https://www.stocktitan.net/sec-filings/ELUT/8-k-elutia-inc-reports-material-event-d48b052d7c2f.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:09:04", "published_display": "14 May 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Reports Q1 2026 Results: Full Earnings Call Transcript", "summary": "Elutia reported increased net sales and gross margin in Q1 2026, driven by advancements in its NXT41 regulatory program and commercialization efforts for breast reconstruction. The company is confident about future FDA clearances for NXT41 and NXT41X, which target a $1.5 billion ", "url": "https://www.sahmcapital.com/news/content/elutia-reports-q1-2026-results-full-earnings-call-transcript-2026-05-15", "source_name": "Sahm", "published_at": "2026-05-14T16:09:30", "published_display": "14 May 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/elutia-report-first-quarter-2026-200500094.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T20:05:00+00:00", "published_display": "30 Apr 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia (NASDAQ: ELUT) seeks approval for larger equity plan and board slate", "summary": "Elutia Inc. (NASDAQ: ELUT) is asking stockholders to approve several proposals at its annual meeting on June 11, 2026. Key items include the re-election of two Class III directors, ratification of PricewaterhouseCoopers LLP as the 2026 auditor, and an amendment to the 2020 Incent", "url": "https://www.stocktitan.net/sec-filings/ELUT/def-14a-elutia-inc-definitive-proxy-statement-1f8f2c4f79a6.html", "source_name": "Stock Titan", "published_at": "2026-04-22T21:09:26", "published_display": "22 Apr 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Announces $13.26 Million Registered Direct Offering", "summary": "Elutia has announced a $13.26 million registered direct offering, selling 3,175,000 shares of its Class A common stock at $3.40 per share and 725,000 prefunded warrants at $3.399 per warrant. The proceeds will be used for working capital and general corporate purposes. Lake Stree", "url": "https://www.stocktitan.net/news/ELUT/elutia-announces-13-26-million-registered-direct-e7mruwrnzayp.html", "source_name": "Stock Titan", "published_at": "2026-04-16T03:09:52", "published_display": "16 Apr 2026 03:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) director receives 6,250 shares as RSUs vest, holding 125,000", "summary": "Elutia (ELUT) director Guido J. Neels received 6,250 shares of Class A Common Stock due to the vesting of restricted stock units (RSUs) on December 10, 2025. These shares were part of a 25,000 RSU grant that vests in four equal installments. Following this transaction, Neels dire", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-21c955d68975.html", "source_name": "Stock Titan", "published_at": "2026-04-14T11:39:38", "published_display": "14 Apr 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia Adopts 2026 Inducement Equity Award Plan", "summary": "Elutia Inc. has adopted its 2026 Inducement Award Plan, authorizing up to 2,000,000 shares of Class A common stock for new hires to attract, retain, and motivate talent without requiring shareholder approval under Nasdaq rules. The plan allows the Compensation Committee to admini", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ELUT/pressreleases/676240/elutia-adopts-2026-inducement-equity-award-plan/", "source_name": "The Globe and Mail", "published_at": "2026-04-03T10:10:23", "published_display": "03 Apr 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win", "summary": "Elutia Inc. (ELUT) faces a new ongoing risk of Nasdaq delisting despite recently regaining compliance with minimum bid price and market value standards. Failure to meet future Nasdaq criteria could lead to reduced trading liquidity, pressure on the share price, and hinder the com", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/763779/elutia-warns-of-ongoing-nasdaq-delisting-risk-despite-recent-compliance-win/", "source_name": "The Globe and Mail", "published_at": "2026-03-28T20:10:13", "published_display": "28 Mar 2026 20:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Elutia (ELUT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTem5iVkNmb0dhcGpBalRCUWpld3NLLUZfQW5CdHQwTFl3Tzl3Zk90ek9qRGExOC1UV0lEZUpKTkhUWFZWWDhlN2c0UlpqZHBFeGNN?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:49:23+00:00", "published_display": "25 Apr 2025 00:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA clears Elutia\u2019s bioenvelope to protect implanted devices", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNVWFyWllnZEZHSTd0YWJLV1JXQ1RlU2JhN0JyTUtMTEVXR0thQ056ODRwSWVWRnRQbVZkckcwY0JaQkktRDhFRC0yVFlaMTdxeFR1V0dUcnpyWEVKX3dVOVZjZnkxR0hnU1VUTFN2S3NZVUs3cW1TMVllUEk3Nk9jNUZYNUFGQnBEWGNPWnVvVF9JYy1rRk5oa1NiTXczSGRqMWc?oc=5", "source_name": "BioWorld News", "published_at": "2024-06-17T07:00:00+00:00", "published_display": "17 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for ELUTIA INC (ELUT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1YQU94UFI4c1lBeEJDNE1objdYWUtGd2dWdi1McEFtNzNfX3R5OENaQ3Z4ZVgzNndDczBnM24yWlJMd2lUZ0VTUW9MTHhjeElOVGJrcnl3R3pMTVVSUUhpQ2lUV3ZReFJKQW1lWXBHMTdLZGFRZEdEYQ?oc=5", "source_name": "Zacks Investment Research", "published_at": "2024-06-02T04:48:57+00:00", "published_display": "02 Jun 2024 04:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) Targets Drug-Eluting Biologic Constructs as the Medical Niche to Power 10x Stock Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5KUkNBYnlaSG03U0ZlcS11Y29UdUE5bE1ET1EzVWhpdWRxdUhPSExaTmlINWx3aHo2a0hVeDhva19pV0xkR0hkOVJ3akNMd0loWXM5d0FfNENxZ2JXTlhkUVN6cTIwVE1ISGtOZzRjYU9yeWNB?oc=5", "source_name": "The Wall Street Transcript", "published_at": "2023-11-27T08:00:00+00:00", "published_display": "27 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Silver Spring's Aziyo Biologics is now Elutia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOeDB4VnZEM3JFcEtzajMtWGRYQU1ydXVKMmN5S01KTkk2d1czVlhhUnQwUjgyTG93MFFSMHVDV0ZEQnNGVVB2b1NfYllXcEVYcDBXYjVxRkFaUVduV1dYRmNFSGtmVVlhRkVNZnpJT0R3amNzNDI4VTRKbkhVMllSbUhzcXg0OHJxZk9RWEx4WTZNYWVpM0ZtaWtR?oc=5", "source_name": "The Business Journals", "published_at": "2023-09-07T07:00:00+00:00", "published_display": "07 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Elutia Inc. (ELUT) Bounces From Support, Tests Key Resistance at $1.01 - RVOL Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOZHVYRGxIbXIzN3VjNkczS3VBR0FaN2I3ZWdNNFNKcXhPQ1VvZE9BWm40WWJlMUxsNVQ4dG90RVU5SGx2ZmR1QUFJZE9PbllGcXVlRlZQakZlNlNuV29EdkVtX1lrZTZMSDlOMVh1b1lKVTNpOXdjdE82TWVQTTVhT2NWdm5lUGJZSS1sd0RfMS0yaDd3MF9vQTJIcmFrZFlUR0ExeTVNaHpfZGEz?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-07T23:47:36+00:00", "published_display": "07 Jul 2026 23:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $5", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOakl3OFRuQXZTMEFZR2lqR2FNWGxFNl8tODdkMENCaE5EM0lESWVmcjQxTTM3SE84Z2dWdHNlV05sT2txMENvWTI2Uk5tMkhCcDZjNFJuWlZ6YTBXQ05fUEszaHF5Q1lLTnQ0WVFSQ2prdmk2TUlkcHQwYXJEdy04VUdQOHRjSGlDb2xjbDJQYkJ1cmFQTEhIRWZ1Vm9TTFR5WkZlMFBaQWVCT3p1NkE?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-07T18:20:20+00:00", "published_display": "07 Jul 2026 18:20", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc Class A Actuals & Estimates (NASDAQ:ELUT)", "summary": "This article provides an overview of Elutia, Inc. (NASDAQ: ELUT) stock performance, financial data, and analyst forecasts. It covers the current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings reports, indicating that analysts have", "url": "https://www.tradingview.com/symbols/NASDAQ-ELUT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:10:08", "published_display": "26 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Elutia Inc For: 22 June By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Elutia Inc. on June 22. It mentions Elutia Inc. with the stock symbol ELUT, which experienced a 4.75% decrease, and includes general market data and news headlines. The content is primarily a placeholder for a fin", "url": "https://ca.investing.com/news/stock-market-news/form-4-elutia-inc-for-22-june-93CH-4701957", "source_name": "Investing.com Canada", "published_at": "2026-06-23T20:11:49", "published_display": "23 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) CEO reports RSU vesting and tax withholding, boosting share holdings", "summary": "Elutia Inc.'s President and CEO, C. Randal Mills, reported the vesting of 22,473 restricted stock units (RSUs) into Class A Common Stock. As part of this transaction, 8,064 shares were withheld by the company to cover tax obligations. Following these transactions, Mills directly ", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-786b9689d1d1.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:40:48", "published_display": "22 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Shareholders Approve Amended Incentive Plan and Governance", "summary": "Elutia shareholders have approved an amended 2020 equity incentive plan, increasing available shares by 3,000,000 Class A common shares and extending the plan's duration. They also elected directors, ratified PricewaterhouseCoopers LLP as auditor, and approved executive compensat", "url": "https://www.tipranks.com/news/company-announcements/elutia-shareholders-approve-amended-incentive-plan-and-governance", "source_name": "TipRanks", "published_at": "2026-06-17T23:39:55", "published_display": "17 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) investors approve equity plan amendment and annual say-on-pay", "summary": "Elutia Inc. (ELUT) stockholders approved an amendment to its 2020 Incentive Award Plan, authorizing an additional 3,000,000 shares for awards and extending the plan's duration. All other proposals also passed, including the election of two Class III directors, the ratification of", "url": "https://www.stocktitan.net/sec-filings/ELUT/8-k-elutia-inc-reports-material-event-46ba78ed20e0.html", "source_name": "Stock Titan", "published_at": "2026-06-17T17:40:54", "published_display": "17 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc. (NASDAQ: ELUT) Files 8-K with Updated Company Information and Key SEC Details \u2013 June 2026", "summary": "Elutia Inc. (NASDAQ: ELUT) filed an 8-K detailing key outcomes from its annual meeting on June 11, 2026. Shareholders approved the First Amendment to the 2020 Incentive Award Plan, elected two Class III Directors, and ratified PricewaterhouseCoopers LLP as auditors for FY2026. Ad", "url": "https://www.minichart.com.sg/2026/06/17/elutia-inc-nasdaq-elut-files-8-k-with-updated-company-information-and-key-sec-details-june-2026/", "source_name": "Minichart", "published_at": "2026-06-17T09:47:00", "published_display": "17 Jun 2026 09:47", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Q1 2026 Earnings: EPS Misses Estimates Amid Operational Challenges - Share Dilution Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPcEZ6WG5zZkNsUjUxbVp5SU5iU05wY0hGNXY3RjU4ZVpkXzY0WVVlWGlROEJGdXEzdUduWW1WYmE5dkZOUzVNVlAxVUhmZHdVd1AwYm1BRDEzaFdqczFLNkFHdGxhRF9TYklaUXd2SDVybjFTRW1wTEllWUFZUzFiRzFPSlFXcHZndVFjYTNGZG15cmlDN1lORDQ4My0zM2xQUVBYcFRwUjNPLWV6QW1QVjVHNE85bHg5RGkw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) director Brigid Makes receives 106,393-share stock option grant", "summary": "Elutia (NASDAQ: ELUT) director Brigid Makes was granted stock options for 106,393 shares of Class A common stock as part of the company\u2019s Non-Employee Director Compensation Program. The options have an exercise price of $0.9600 per share and expire on June 11, 2036. This grant is", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-5d91513660b4.html", "source_name": "Stock Titan", "published_at": "2026-06-16T05:10:31", "published_display": "16 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) director awarded 106K stock options as compensation", "summary": "Elutia (NASDAQ: ELUT) director David Colpman received a grant of 106,393 stock options as compensation, with an exercise price of $0.96 per share. These options are not an open-market trade and will vest upon the earlier of the day before Elutia's first annual meeting following t", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-c3526816a7b5.html", "source_name": "Stock Titan", "published_at": "2026-06-16T04:40:26", "published_display": "16 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) grants director Kevin Rakin 159,590 stock options", "summary": "Elutia Inc. director and 10% owner Kevin Rakin has been granted 159,590 stock options for Class A Common Stock at an exercise price of $0.96 per share. These options, part of the company's Non-Employee Director Compensation Program, will vest based on his continued board service ", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-d274f8a43f00.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:40:26", "published_display": "15 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) director receives 106,393 stock options at $0.96 strike", "summary": "Elutia (NASDAQ: ELUT) director Guido J. Neels was granted 106,393 stock options with an exercise price of $0.96 per share. This grant was made automatically under the company\u2019s Non-Employee Director Compensation Program. The options vest upon the earlier of the first annual meeti", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-c03b46b5b2c5.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:40:26", "published_display": "15 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ELUTIA (ELUT) CSO reports RSU vesting and tax withholding share disposition", "summary": "ELUTIA's Chief Scientific Officer, Michelle LeRoux Williams, reported the vesting of 12,500 restricted stock units (RSUs) into Class A Common Stock on June 10, 2026. Concurrently, 4,269 shares were withheld at $1.04 each to cover tax obligations. Following these transactions, Wil", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-212e7de2564d.html", "source_name": "Stock Titan", "published_at": "2026-06-13T03:38:56", "published_display": "13 Jun 2026 03:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) CFO reports RSU vesting and tax withholding event", "summary": "Elutia Inc.'s CFO, Matthew Ferguson, reported the vesting of 12,500 restricted stock units (RSUs) into Class A common stock. To cover tax withholding obligations, 4,485 shares were withheld by the company at an implied price of $1.04 per share. Following these transactions, Fergu", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-b44f85cfae02.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:56", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) CEO RSUs vest; shares withheld to cover taxes", "summary": "Elutia Inc.'s President and CEO, C. Randal Mills, had 27,083 restricted stock units (RSUs) vest on June 10, 2026, which converted into Class A common shares. To cover tax withholding requirements, 9,718 Class A shares were withheld by the issuer at $1.04 per share. Following thes", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-1c680e41e29b.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:38:56", "published_display": "12 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia to Present at Planet MicroCap Showcase 2026 on June 17th", "summary": "Elutia Inc. will present at the Planet MicroCap Showcase 2026 on June 17th, with CEO Dr. Randy Mills and CSO Dr. Michelle Williams hosting one-on-one meetings with investors. Management will discuss Elutia's drug-eluting biomatrix technology, which aims to address post-surgical i", "url": "https://sg.finance.yahoo.com/news/elutia-present-planet-microcap-showcase-200500866.html", "source_name": "Market source", "published_at": "2026-06-11T20:05:00", "published_display": "11 Jun 2026 20:05", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc. (ELUT) Slips Nearly 5% as Stock Tests Key Support Levels - Shakeout Pattern", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNSGhEZVROeE9CblRGMFExQjFJUTE0eUowZGZ6NGhya05HVEtILXA0eE8xRGxxM2VoZkZ3ZXliRVgwWVV2bXdXV2prbkQxSmZQeW9TVUVRQjMzQnFfSlJIMnhILV9GUVN2SnhJRmRwT3Y3SHlRQmxPQm1Janc3NHR5ZFNYSmF2dHRvX2lpMnBPRHZoT3hndURqbTE1bHkySEZOVG5saE1PajJlRGxv?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Despite Elutia's Pullback, Insiders Still Gained US$75k", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) director gifts shares and updates trust, HighCape stakes", "summary": "Kevin Rakin, a director and ten percent owner of Elutia (ELUT), along with affiliated HighCape entities, reported internal share movements rather than market trades. These transactions included a bona fide gift of 70,000 shares and a 50,000-share distribution from trusts to benef", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-a218a7430792.html", "source_name": "Stock Titan", "published_at": "2026-06-02T20:10:18", "published_display": "02 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)", "summary": "Elutia Inc. announced that it granted equity awards to one new employee on May 13, 2026, as an inducement award under its 2026 Inducement Award Plan. The award, consisting of 48,000 non-qualified stock options, was approved by the Compensation Committee and granted in accordance ", "url": "https://www.sahmcapital.com/news/content/elutia-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4-2026-05-18", "source_name": "Sahm", "published_at": "2026-05-19T08:09:39", "published_display": "19 May 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Reports First Quarter 2026 Results and Highlights", "summary": "Elutia Inc. reported its first quarter 2026 results, highlighting significant progress in its NXT-41x drug-eluting biomatrix technology aimed at the $1.5 billion U.S. plastic and reconstructive surgery market. The company advanced its FDA review process, brought a new automated m", "url": "https://www.globenewswire.com/news-release/2026/05/14/3295372/0/en/elutia-reports-first-quarter-2026-results-and-highlights-nxt-41x-progress-toward-1-5-billion-u-s-plastic-and-reconstructive-surgery-market.html", "source_name": "GlobeNewswire", "published_at": "2026-05-17T06:40:20", "published_display": "17 May 2026 06:40", "sentiment": "positive", "sentiment_pct": 78, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "About Us | Oil & Gas Journal - Elutia, Inc. - Class A Common Stock (Nasdaq:ELUT) Stock Quote", "summary": "This page provides a detailed stock quote for Elutia, Inc. (Nasdaq: ELUT), including current trading information, historical prices, performance data, and an archive of recent news and earnings reports. The stock closed at $1.030 on May 15, 2026, with a slight decrease of 0.96%, ", "url": "https://markets.financialcontent.com/pennwell.pennenergy/quote?Symbol=537%3A2578417618", "source_name": "FinancialContent", "published_at": "2026-05-16T04:10:08", "published_display": "16 May 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/5f18ce7a-19a5-3ce2-a378-2aebbed03faf/elutia-%28elut%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-15T12:58:03+00:00", "published_display": "15 May 2026 12:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/b34b80a4-9c37-35c8-a41b-35f8ded35f44/elutia-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-15T12:30:00+00:00", "published_display": "15 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia to Present at the 16th Annual LD Micro Invitational on May 18th", "summary": "Elutia Inc. (Nasdaq: ELUT) announced that its CEO, Dr. Randy Mills, and CFO, Matt Ferguson, will present at the 16th Annual LD Micro Invitational on May 18, 2026. They will discuss the company's drug-eluting biomatrix technology, which aims to address post-surgical infection in i", "url": "https://www.sahmcapital.com/news/content/elutia-to-present-at-the-16th-annual-ld-micro-invitational-on-may-18th-2026-05-14", "source_name": "Sahm", "published_at": "2026-05-15T08:39:02", "published_display": "15 May 2026 08:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Shifts", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/elutia-inc-elut-q1-2026-050112032.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:01:12+00:00", "published_display": "15 May 2026 05:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/elutia-reports-first-quarter-2026-200500939.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T20:05:00+00:00", "published_display": "14 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia to Present at the 16th Annual LD Micro Invitational May 18th", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/elutia-present-16th-annual-ld-200100167.html", "source_name": "TMX Newsfile", "published_at": "2026-05-14T20:01:00+00:00", "published_display": "14 May 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) Q1 loss deepens while NXT-41 pipeline and margins progress", "summary": "Elutia Inc. (NASDAQ: ELUT) reported a wider net loss of $7.5 million in Q1 2026, despite slightly higher revenue of $3.1 million, as the company continues to invest in its drug-eluting biomatrix platform. Gross margins improved significantly, with GAAP at 57.9% and adjusted at 66", "url": "https://www.stocktitan.net/sec-filings/ELUT/8-k-elutia-inc-reports-material-event-d48b052d7c2f.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:09:04", "published_display": "14 May 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Reports Q1 2026 Results: Full Earnings Call Transcript", "summary": "Elutia reported increased net sales and gross margin in Q1 2026, driven by advancements in its NXT41 regulatory program and commercialization efforts for breast reconstruction. The company is confident about future FDA clearances for NXT41 and NXT41X, which target a $1.5 billion ", "url": "https://www.sahmcapital.com/news/content/elutia-reports-q1-2026-results-full-earnings-call-transcript-2026-05-15", "source_name": "Sahm", "published_at": "2026-05-14T16:09:30", "published_display": "14 May 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/elutia-report-first-quarter-2026-200500094.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T20:05:00+00:00", "published_display": "30 Apr 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) seeks approval for larger equity plan and board slate", "summary": "Elutia Inc. (NASDAQ: ELUT) is asking stockholders to approve several proposals at its annual meeting on June 11, 2026. Key items include the re-election of two Class III directors, ratification of PricewaterhouseCoopers LLP as the 2026 auditor, and an amendment to the 2020 Incent", "url": "https://www.stocktitan.net/sec-filings/ELUT/def-14a-elutia-inc-definitive-proxy-statement-1f8f2c4f79a6.html", "source_name": "Stock Titan", "published_at": "2026-04-22T21:09:26", "published_display": "22 Apr 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Announces $13.26 Million Registered Direct Offering", "summary": "Elutia has announced a $13.26 million registered direct offering, selling 3,175,000 shares of its Class A common stock at $3.40 per share and 725,000 prefunded warrants at $3.399 per warrant. The proceeds will be used for working capital and general corporate purposes. Lake Stree", "url": "https://www.stocktitan.net/news/ELUT/elutia-announces-13-26-million-registered-direct-e7mruwrnzayp.html", "source_name": "Stock Titan", "published_at": "2026-04-16T03:09:52", "published_display": "16 Apr 2026 03:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) director receives 6,250 shares as RSUs vest, holding 125,000", "summary": "Elutia (ELUT) director Guido J. Neels received 6,250 shares of Class A Common Stock due to the vesting of restricted stock units (RSUs) on December 10, 2025. These shares were part of a 25,000 RSU grant that vests in four equal installments. Following this transaction, Neels dire", "url": "https://www.stocktitan.net/sec-filings/ELUT/form-4-elutia-inc-insider-trading-activity-21c955d68975.html", "source_name": "Stock Titan", "published_at": "2026-04-14T11:39:38", "published_display": "14 Apr 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Adopts 2026 Inducement Equity Award Plan", "summary": "Elutia Inc. has adopted its 2026 Inducement Award Plan, authorizing up to 2,000,000 shares of Class A common stock for new hires to attract, retain, and motivate talent without requiring shareholder approval under Nasdaq rules. The plan allows the Compensation Committee to admini", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ELUT/pressreleases/676240/elutia-adopts-2026-inducement-equity-award-plan/", "source_name": "The Globe and Mail", "published_at": "2026-04-03T10:10:23", "published_display": "03 Apr 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win", "summary": "Elutia Inc. (ELUT) faces a new ongoing risk of Nasdaq delisting despite recently regaining compliance with minimum bid price and market value standards. Failure to meet future Nasdaq criteria could lead to reduced trading liquidity, pressure on the share price, and hinder the com", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/763779/elutia-warns-of-ongoing-nasdaq-delisting-risk-despite-recent-compliance-win/", "source_name": "The Globe and Mail", "published_at": "2026-03-28T20:10:13", "published_display": "28 Mar 2026 20:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (ELUT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTem5iVkNmb0dhcGpBalRCUWpld3NLLUZfQW5CdHQwTFl3Tzl3Zk90ek9qRGExOC1UV0lEZUpKTkhUWFZWWDhlN2c0UlpqZHBFeGNN?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:49:23+00:00", "published_display": "25 Apr 2025 00:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA clears Elutia\u2019s bioenvelope to protect implanted devices", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNVWFyWllnZEZHSTd0YWJLV1JXQ1RlU2JhN0JyTUtMTEVXR0thQ056ODRwSWVWRnRQbVZkckcwY0JaQkktRDhFRC0yVFlaMTdxeFR1V0dUcnpyWEVKX3dVOVZjZnkxR0hnU1VUTFN2S3NZVUs3cW1TMVllUEk3Nk9jNUZYNUFGQnBEWGNPWnVvVF9JYy1rRk5oa1NiTXczSGRqMWc?oc=5", "source_name": "BioWorld News", "published_at": "2024-06-17T07:00:00+00:00", "published_display": "17 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for ELUTIA INC (ELUT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1YQU94UFI4c1lBeEJDNE1objdYWUtGd2dWdi1McEFtNzNfX3R5OENaQ3Z4ZVgzNndDczBnM24yWlJMd2lUZ0VTUW9MTHhjeElOVGJrcnl3R3pMTVVSUUhpQ2lUV3ZReFJKQW1lWXBHMTdLZGFRZEdEYQ?oc=5", "source_name": "Zacks Investment Research", "published_at": "2024-06-02T04:48:57+00:00", "published_display": "02 Jun 2024 04:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Elutia (NASDAQ: ELUT) Targets Drug-Eluting Biologic Constructs as the Medical Niche to Power 10x Stock Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5KUkNBYnlaSG03U0ZlcS11Y29UdUE5bE1ET1EzVWhpdWRxdUhPSExaTmlINWx3aHo2a0hVeDhva19pV0xkR0hkOVJ3akNMd0loWXM5d0FfNENxZ2JXTlhkUVN6cTIwVE1ISGtOZzRjYU9yeWNB?oc=5", "source_name": "The Wall Street Transcript", "published_at": "2023-11-27T08:00:00+00:00", "published_display": "27 Nov 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Silver Spring's Aziyo Biologics is now Elutia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOeDB4VnZEM3JFcEtzajMtWGRYQU1ydXVKMmN5S01KTkk2d1czVlhhUnQwUjgyTG93MFFSMHVDV0ZEQnNGVVB2b1NfYllXcEVYcDBXYjVxRkFaUVduV1dYRmNFSGtmVVlhRkVNZnpJT0R3amNzNDI4VTRKbkhVMllSbUhzcXg0OHJxZk9RWEx4WTZNYWVpM0ZtaWtR?oc=5", "source_name": "The Business Journals", "published_at": "2023-09-07T07:00:00+00:00", "published_display": "07 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 94, "total_relevant": 53, "sentiment_summary": {"positive": 6, "negative": 3, "neutral": 44, "score": 51, "total": 53, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 14.3, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 10.59, "count": 22}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.9, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 0.96, "latest_week": "2026-07-10", "one_week_move": 3.3, "four_week_move": 0.3, "twelve_week_move": -16.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.584636, "market_dynamics_buy_signal": false, "relative_strength": -27.29228, "fair_value_gap": -58.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 53.2902, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.3% over one week, +0.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 15}, {"label": "Market source", "count": 10}, {"label": "Sahm", "count": 3}, {"label": "GlobeNewswire", "count": 3}, {"label": "dars.gov.et", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "\u5bcc\u9014\u725b\u725b", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 42}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 22}, {"label": "Regulatory and legal", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "42", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.3% over one week, +0.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Elutia Inc. (ELUT) Bounces From Support, Tests Key Resistance at $1.01 - RVOL Breakout"}], "updated_at": "2026-07-16T09:47:31.996465+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}